Insider Transactions in Q1 2024 at Ovid Therapeutics Inc. (OVID)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Jeremy M Levin CEO |
BUY
Open market or private purchase
|
Direct |
18,248
+0.5%
|
$36,496
$2.76 P/Share
|
|
Feb 22
2024
|
Jason Tardio Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|
|
Feb 22
2024
|
Thomas Michael Perone General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|
|
Feb 22
2024
|
Jeffrey A Rona CBFO |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+50.0%
|
-
|